USPTO 2015–2025 USPTO PatentsView US Corporation

VT Idirect, Inc.

USPTO PatentsView assignee record - 15 granted patents across 10 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04B (Transmission).

RSS updates for this company

The verdict

According to USPTO PatentsView, VT ranks #19,339 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 10 technology areas.

#19,339
of 49,997 US assignees by volume
42nd percentile
by Innovation Score (32.6/100)
19.7
avg claims per patent
-85%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19339 · US Corporation #19,339 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 15 grants
  • MID-PACK #19,339/49,997
  • PHOTO-FINISH Valo Early Discovery
  • CPC-FOCUS H04B · 10 areas
  • INNOV-THIN 32.6/100
  • CLAIMS-RICH 19.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -85% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Valo Early Discovery, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How VT’s 32.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around VT

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows VT's Innovation Score is 32.6/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for VT?

Each dot is one of VT’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). VT’s own 19.7 claims/patent is ABOVE the 18.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

VT vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 010203040 Granted patents (volume) Avg claims / patent Vifor Fresenius Medical Care Renal Pharma Ltd - 15, 36.73Vifor Fresenius M…Vinventions USA, LLC - 15, 38.07Vinventions USAVLN Advanced Technologies Inc. - 15, 11.07VLN AdvancedVogelsang GMBH & Co KG - 15, 22.67Vogelsang & KGValo Early Discovery, Inc. - 15, 18Valo Early Discov…Valve Medical Ltd. - 15, 23.73Valve MedicalVascular Imaging Corporation - 15, 15.07Vascular ImagingVaxxas Pty Limited - 15, 16.53Vaxxas PtyVT Idirect, Inc. - 15, 19.73VT Idirect
VT vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where VT's grants concentrate

VT Idirect, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 73.3% of grants classified under H04B (Transmission). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2016. By volume, VT sits between Vifor Fresenius Medical Care Renal Pharma Ltd and Vaxxas Pty Limited.

Who files at VT's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows VT holds 15 patents at rank #19,317, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near VT

By rank, the assignees closest to #19,317 in granted patent volume.

Leaders in H04B (Transmission)

Other assignees with the most granted patents in VT's primary technology class.

VT's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 201520162017201820192020 2
USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
VT Idirect, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 13.3%
2016 1 6.7%
2017 6 40.0%
2018 2 13.3%
2019 2 13.3%
2020 2 13.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

VT Idirect, Inc.'s patent record in context - here's where to go next.

  • VT Idirect, Inc.'s lead technology class is H04B (Transmission), 73.3% of its portfolio - see every assignee active in that class. Explore H04B
  • Ranked #19,339 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare VT Idirect, Inc. against Vifor Fresenius Medical Care Renal Pharma Ltd, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 32.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.